Compare · ARM vs DVLT
ARM vs DVLT
Side-by-side comparison of Arm Holdings plc (ARM) and Datavault AI Inc. (DVLT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ARM and DVLT operate in Semiconductors (Technology), so they compete in similar markets.
- ARM is the larger of the two at $260.47B, about 1946.5x DVLT ($133.8M).
- DVLT has been more active in the news (23 items in the past 4 weeks vs 6 for ARM).
- ARM has more recent analyst coverage (25 ratings vs 0 for DVLT).
- Company
- Arm Holdings plc
- Datavault AI Inc.
- Price
- $227.75-6.92%
- $0.13-6.92%
- Market cap
- $260.47B
- $133.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Semiconductors
- Semiconductors
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2018
- News (4w)
- 6
- 23
- Recent ratings
- 25
- 0
Latest ARM
- A 20% Drop in Smartphone Shipments Shows Who Wins When Memory Gets Expensive
- AI Revenue Questions Pull Semiconductor Stocks Off October Highs
- The Unconventional Route to Fusion Power Just Hit a World First
- Arm Announces Earnings Release Date for Second Quarter Fiscal Year Ending 2027
- Chief Financial Officer Child Jason sold $3,120,000 worth of Ordinary Shares (10,400 units at $300.00) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 153,442 units (SEC Form 4)
- SEC Form 144 filed by Arm Holdings plc
- SEC Form 6-K filed by Arm Holdings plc
- SEC Form 4 filed by Chief Commercial Officer Abbey William
- Chief Executive Officer Haas Rene A. was granted 64 units of Ordinary Shares, increasing direct ownership by 0.02% to 338,666 units (SEC Form 4)
- SEC Form 6-K filed by Arm Holdings plc
Latest DVLT
- SEC Form 3 filed by Datavault AI Inc.
- DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
- SEC Form 8-K filed by Datavault AI Inc.
- SEC Form 8-K filed by Datavault AI Inc.
- Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
- DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
- Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors
- Datavault AI to Debut Tort Token Capabilities at the Mass Torts Made Perfect Conference in Las Vegas
- DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
- DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers